Effect of low molecular weight heparin (enoxaparin) on congenital cataract surgery

Ihsan Caça1, Alparslan Sahin, Abdullah Kürsat Cingü

  • 1Department of Ophthalmology, Dicle University Faculty of Medicine, Diyarbakır, Turkey.

Insights

Intracameral enoxaparin significantly reduced postoperative inflammation in congenital cataract surgery. The anti-inflammatory effect of enoxaparin was dose-dependent, with lower complication rates observed in treated groups.

Area of Science:

  • Ophthalmology
  • Pediatric Surgery
  • Pharmacology

Background:

  • Congenital cataracts require surgical intervention, often leading to postoperative inflammation.
  • Managing intraocular inflammation is crucial for favorable surgical outcomes in pediatric cataract patients.

Purpose of the Study:

  • To evaluate the efficacy of varying doses of intracameral enoxaparin in mitigating postoperative inflammatory responses following congenital cataract surgery.
  • To determine if the anti-inflammatory effect of enoxaparin is dose-dependent in this context.

Main Methods:

  • A prospective, randomized controlled trial involving 80 eyes of 53 children with congenital cataracts.
  • Eyes underwent primary posterior capsulorrhexis and intraocular lens (IOL) implantation.
  • Participants were divided into four groups: one receiving balanced salt solution (BSS) alone, and three receiving BSS with 40mg, 20mg, or 10mg of enoxaparin.

Main Results:

  • Intracameral enoxaparin significantly reduced the number of inflammatory cells in the anterior chamber compared to the control group (P<0.001).
  • Lower rates of fibrin formation and IOL precipitates were observed in enoxaparin-treated groups, particularly at higher doses.
  • No significant differences in synechiae formation or IOL subluxation were noted across the groups.

Conclusions:

  • Intracameral enoxaparin effectively decreases postoperative inflammatory complications in congenital cataract surgery.
  • The anti-inflammatory benefits of enoxaparin were found to be dose-dependent.
  • Enoxaparin represents a promising adjunct for managing inflammation in pediatric cataract surgery.
Abstract

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...